Panacea Life Sciences Holdings, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Panacea Life Sciences Holdings, Inc. (PLSH) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $348.51 thousand as of 2024-03-31, per its 10-Q filed 2024-05-06.
Discontinued › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2024-05-06
- 2024-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $348.51K.
- 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $375.56K.
- 2023-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $355.16K.
- 2023-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $378.70K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2024-03-31 | $348.51K 10-Q · filed 2024-05-06 |
| 2023-12-31 | $375.56K 10-K · filed 2024-04-01 |
| 2023-09-30 | $355.16K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $378.70K 10-Q · filed 2023-08-15 |
| 2023-03-31 | $402.91K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $427.80K 10-K · filed 2023-03-30 |
| 2022-09-30 | $453.34K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $479.53K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $506.37K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $533.85K 10-K · filed 2022-03-31 |
| 2021-09-30 | $561.96K 10-Q/A · filed 2021-12-20 |
| 2021-06-30 | $590.69K 10-Q/A · filed 2021-12-20 |
| 2020-09-30 | $21.21K 10-Q · filed 2020-11-18 |
| 2020-06-30 | $28.64K 10-Q · filed 2020-08-19 |
| 2020-03-31 | $471.23K 10-Q · filed 2020-06-29 |
| 2019-12-31 | $526.76K 10-K · filed 2020-05-22 |
| 2019-09-30 | $584.75K 10-Q · filed 2019-11-14 |